Trxade Health Inc (MEDS)
6.29
+0.28
(+4.66%)
USD |
NASDAQ |
May 03, 16:00
6.15
-0.14
(-2.23%)
After-Hours: 20:00
Trxade Health Research and Development Expense (Quarterly): 0.3665M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.3665M |
| September 30, 2023 | 0.4106M |
| June 30, 2023 | 0.4414M |
| March 31, 2023 | 0.2333M |
| December 31, 2022 | 0.3023M |
| September 30, 2022 | 0.2386M |
| June 30, 2022 | 0.2981M |
| March 31, 2022 | 0.2458M |
| December 31, 2021 | 0.2216M |
| September 30, 2021 | 0.3386M |
| June 30, 2021 | 0.1246M |
| March 31, 2021 | 0.2149M |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| September 30, 2009 | 0.00 |
| June 30, 2009 | |
| March 31, 2009 | 0.007M |
| December 31, 2008 | |
| September 30, 2008 | |
| June 30, 2008 | |
| March 31, 2008 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.1246M
Minimum
Jun 2021
0.4414M
Maximum
Jun 2023
0.2864M
Average
0.2719M
Median
Research and Development Expense (Quarterly) Benchmarks
| HealthStream Inc | 12.03M |
| HealthEquity Inc | 55.24M |
| Accolade Inc | 24.19M |
| Simulations Plus Inc | 1.312M |
| Schrodinger Inc | 50.61M |